[1] B. ANDERSEN N W. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.[J]. The Ukrainian Biochemical Journal, 2002, 13 1: 443-450. DOI:
10.1042/bj20020153[2] B. ANDERSEN. Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.[J]. The Ukrainian Biochemical Journal, 1999, 17 1: 545-550. DOI:
10.1042/bj3420545[3] ANNE B. WALLS. Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity[J]. Journal of Neurochemistry, 2008, 105 4: 1462-1470. DOI:
10.1111/j.1471-4159.2008.05250.x[4] KELD FOSGERAU . Kinetic and Functional Characterization of 1,4-Dideoxy-1,4-imino-d-arabinitol: A Potent Inhibitor of Glycogen Phosphorylase with Anti-hyperglyceamic Effect in ob/ob Mice[J]. Archives of biochemistry and biophysics, 2000, 380 2: Pages 274-284. DOI:
10.1006/abbi.2000.1930[5] GIBBS M. Role of Glycogenolysis in Memory and Learning: Regulation by Noradrenaline, Serotonin and ATP[J]. Frontiers in Integrative Neuroscience, 2016, 9 1. DOI:
10.3389/fnint.2015.00070[6] NEPHTALI MARINA. Brainstem hypoxia contributes to the development of hypertension in the spontaneously hypertensive rat.[J]. ACS Applied Nano Materials, 2015: 775-783. DOI:
10.1161/hypertensionaha.114.04683